Stock report · Delisted · Nasdaq

DMD Digital Health Connections Group Inc (APTOF)

1.69USD Delisted Final close · Jul 2, 2026

APTOF no longer trades. DMD Digital Health Connections Group was delisted from the Nasdaq in July 2026.

All prices on this page are historical. The last trade was on July 2, 2026, at $1.69.

APTOF stock price history

Loading chart…
Split-adjusted closing prices, 2014–2026

Final trading statistics

Final close
$1.69
Final trading day
Jul 2, 2026
Market cap at delisting
$4.31M
Shares outstanding
2.55M
Final 52-week range
$0.86 – $1.85
Avg. volume (final 3 mo.)
2,143
All-time high
$850505.44 · Mar 2000
All-time low
$0.80 · Jun 2025
Return since IPO
-97.9%
Beta
0.34
Book value / share
−$13.58
Price / book
-0.12

About DMD Digital Health Connections Group Inc

This clinical-stage biotech company, described as Aptose Biosciences Inc., discovered and developed precision cancer drugs, mainly in the U.S. Its lead oral kinase inhibitor, tuspetinib (HM43239), was a once-daily pill that had completed a Phase 1/2 trial aimed at kinases active in myeloid cancers, such as acute myeloid leukemia and higher risk myelodysplastic syndromes.

It held license agreements with the National Cancer Institute for clinical development of tuspetinib and with Hanmi Pharmaceutical Co Ltd. covering research, development and sales of the drug. Incorporated in 1986 and based in Toronto, Canada, the company was known as Lorus Therapeutics Inc. until August 2014.

Trading as DMD Digital Health Connections Group, its shares were delisted from the Nasdaq in July 2026, with a last trade on July 2, 2026 at $1.69.

Exchange (former)
Nasdaq
Sector
Healthcare
Industry
Biotechnology
Headquarters
Toronto, ON
Employees
14
IPO date
October 23, 2014
Delisted
July 2, 2026

DMD Digital Health Connections Group financials before the delisting

The last 5 fiscal years DMD Digital Health Connections Group reported as a public company, fiscal year ending December.

APTOF revenue and net income

RevenueNet income

APTOF earnings per share

Earnings per share

APTOF annual financials

DMD Digital Health Connections Group Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2025$0.00−$25.5M—
FY2024$0.00−$25.4M−$269.20
FY2023$0.00−$51.2M—
FY2022$0.00−$41.8M−$153.45
FY2021$0.00−$65.4M−$207.27

Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.

DMD Digital Health Connections Group stock FAQ

What happened to DMD Digital Health Connections Group stock?

DMD Digital Health Connections Group was delisted from the Nasdaq in July 2026. The final close was $1.69 on July 2, 2026.

Can I still buy APTOF stock?

No. APTOF is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on July 2, 2026.

What was the last price of APTOF?

APTOF last closed at $1.69 on July 2, 2026, which valued the company at about $4.31M.

How did DMD Digital Health Connections Group do in its last full fiscal year?

In fiscal 2025, its last full year as a public company, DMD Digital Health Connections Group reported revenue of $0.00 and net income of −$25.5M.

When did DMD Digital Health Connections Group go public?

DMD Digital Health Connections Group shares started trading on October 23, 2014.

APTOF no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.